drugset / Trial / NCT05941247
A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers
Phase 1
Completed
12 enrolled
Ganzhou Hemay Pharmaceutical Co., Ltd
Hemay Pharmaceutical PTY. LTD. · collab
NaSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to assess the safety and tolerability of single and multiple oral doses of Hemay005 tablets in healthy Caucasian adult volunteers.
Timeline
- Start
- 2023-07-17
- Primary completion
- 2023-08-08
- Completion
- 2023-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUFEMILAST | Small molecule | 60 mg | Oral |
Indications
No indication recorded.